These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 17470690
1. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Bennett CL, Calhoun EA. Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690 [Abstract] [Full Text] [Related]
2. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy. Caggiano V, Weiss RV, Rickert TS, Linde-Zwirble WT. Cancer; 2005 May 01; 103(9):1916-24. PubMed ID: 15751024 [Abstract] [Full Text] [Related]
3. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates. Yelin E, Cisternas MG, Pasta DJ, Trupin L, Murphy L, Helmick CG. Arthritis Rheum; 2004 Jul 01; 50(7):2317-26. PubMed ID: 15248233 [Abstract] [Full Text] [Related]
4. Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL. Oncologist; 2001 Jul 01; 6(5):441-5. PubMed ID: 11675522 [Abstract] [Full Text] [Related]
5. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. Santolaya ME, Alvarez AM, Avilés CL, Becker A, Cofré J, Cumsille MA, O'Ryan ML, Payá E, Salgado C, Silva P, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M. J Clin Oncol; 2004 Sep 15; 22(18):3784-9. PubMed ID: 15365075 [Abstract] [Full Text] [Related]
10. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, Bennett CL. Cancer; 2008 Sep 15; 113(6):1446-52. PubMed ID: 18683883 [Abstract] [Full Text] [Related]
11. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J, ENIA Study Group. Curr Med Res Opin; 2009 Oct 15; 25(10):2533-42. PubMed ID: 19722781 [Abstract] [Full Text] [Related]
12. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim. Annemans L, Van Overbeke N, Standaert B, Van Belle S. J Nurs Manag; 2005 May 15; 13(3):265-74. PubMed ID: 15819840 [Abstract] [Full Text] [Related]
13. Economic costs of diabetes in the U.S. In 2007. American Diabetes Association. Diabetes Care; 2008 Mar 15; 31(3):596-615. PubMed ID: 18308683 [Abstract] [Full Text] [Related]